Mar 25, 2022 This Week in Cardiology

Mar 25, 2022 This Week in Cardiology

AF ablation vs rate control in HF, TAVI vs SAVR, atherosclerosis, and surrogate endpoints in observational studies are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I – AF ablation vs Rate Control

RAFT-AF, Despite Itself, Hints at Advantage for Ablation Rhythm Control in Heart Failure With AF https://www.medscape.com/viewarticle/951326

• Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial https://www.ahajournals.org/doi/suppl/10.1161/CIRCULATIONAHA.121.057095

• Catheter Ablation for Atrial Fibrillation with Heart Failure

https://www.nejm.org/doi/full/10.1056/nejmoa1707855

• Lenient versus Strict Rate Control in Patients with Atrial Fibrillation https://www.nejm.org/doi/full/10.1056/nejmoa1001337

II – TAVI vs SAVR

Surgery Groups Push Back on VARC-3 Valve Trial Definitions https://www.medscape.com/viewarticle/970753

• Joint Surgical Associations (EACTS, LACES, ASCVTS, AATS, and STS) Position Statement Regarding the VARC-3 Definitions for Aortic Valve Clinical Research https://doi.org/10.1093/ejcts/ezac110

III – Atherosclerosis

Medical Management Best for Atherosclerotic Stroke: New AAN Guidance

https://www.medscape.com/viewarticle/970886

• Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory https://n.neurology.org/content/98/12/486

IV – ECHO parameters with Rhythm Control

Global Gains in Heart Function From Early AF Rhythm Control

https://www.medscape.com/viewarticle/970329

• Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation https://doi.org/10.1016/j.jacc.2021.12.029

• Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation https://doi.org/10.1016/j.jacc.2021.12.028

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact

news@medscape.net

Jaksot(388)

Jan 24, 2020 This Week in Cardiology Podcast

Jan 24, 2020 This Week in Cardiology Podcast

Executive physicals, coconut fat, leadless pacemakers, coils, and independent nurse practitioners and physician assistants are the topics discussed by Dr. John Mandrola in this week's podcast.

24 Tammi 202017min

Jan 17, 2020 This Week in Cardiology Podcast

Jan 17, 2020 This Week in Cardiology Podcast

EXCEL, amyloid cardiomyopathy, drug prices, palliative care in cardiology, and gender bias are the topics covered by Dr John Mandrola in this week's podcast.

17 Tammi 202015min

Jan 10, 2020 This Week in Cardiology Podcast

Jan 10, 2020 This Week in Cardiology Podcast

The Excel trial, peripartum cardiomyopathy, marathoning, hot-spotting, and leadership in innovation are the topics discussed by Dr. John Mandrola in this week's podcast.

10 Tammi 202019min

Jan 3, 2020 This Week in Cardiology Podcast

Jan 3, 2020 This Week in Cardiology Podcast

The EXCEL debate, the NOBLE trial, alcohol and AF, cardiac devices, and hospital consolidation are the topics covered by John Mandrola, MD, in this week's podcast.

3 Tammi 202019min

Dec 20, 2019 This Week in Cardiology

Dec 20, 2019 This Week in Cardiology

A risk score for device infection, conflicts of interest, the Fragility Index, rhythm vs rate control for AF in HFpEF, and year-end highlights are discussed by John Mandrola, MD, in this week's podcast.

20 Joulu 201919min

Dec 13, 2019 This Week in Cardiology

Dec 13, 2019 This Week in Cardiology

The EXCEL trial controversy, and Dr John Mandrola's experience with vernakalant at FDA are the topics covered in this week's podcast.

13 Joulu 201919min

Dec 6, 2019 This Week in Cardiology Podcast

Dec 6, 2019 This Week in Cardiology Podcast

Vernakalent, CV death in cancer patients, dapagliflozin, and sacubitril/valsartan are the topics Dr. John Mandrola discusses in this week's podcast.

5 Joulu 201920min

Nov 22, 2019 This Week in Cardiology Podcast

Nov 22, 2019 This Week in Cardiology Podcast

Highlights from the 2019 AHA meeting are analyzed by Dr John Mandrola in this week's podcast.

22 Marras 201924min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
tiedekulma-podcast
rss-duodecim-lehti
docemilia
rss-poliisin-mieli
mielipaivakirja
rss-radplus
rss-tiedetta-vai-tarinaa
rss-tervetta-skeptisyytta
radio-antro
filocast-filosofian-perusteet
rss-kasvatuspsykologiaa-kaikille
rss-laakaripodi
menologeja-tutkimusmatka-vaihdevuosiin
rss-politiikasta-podcast
rss-ilmasto-kriisissa
rss-taivaanranta
rss-lihavuudesta-podcast